Associate Vice President, External Innovation - Neuroscience

Eli Lilly and CompanyIndianapolis, Boston, Indiana, MassachusettsOn-siteFull-timePrincipal, 12–15+ yearsListed 35 minutes ago

Apply now

About this role

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

Purpose

External Innovation is a critical growth lever for Lilly's portfolio strategy and long-term company success. As internal pipelines are increasingly complemented by external science, the identification, rigorous evaluation, and disciplined advancement of external opportunities represent a substantial and growing investment across the enterprise — one that materially shapes Neuroscience's competitive position and Lilly's ability to deliver breakthrough medicines. Roughly half of Lilly's new product launches over the past decade were enabled by external innovation. In Neuroscience this spans research collaborations, platform and asset licenses, equity investments and acquisitions of private and public companies, across modalities from small molecules and antibodies to oligonucleotides, gene therapies and blood–brain barrier delivery technologies.

The AVP, External Innovation, Neuroscience owns external innovation strategy and execution across the full Neuroscience portfolio — covering all indications of interest within Neurodegeneration, Pain, Psychiatry, and Sleep-Wake disorders, together with accountability for whitespace and adjacency development — and across all stages, from academic and discovery-stage science through late-phase clinical and marketed assets. This role sets external innovation strategy with senior management; supervises and leads partnering projects end-to-end from opportunity identification through scientific due diligence, recommendation and deal completion; ensures timely execution of the external innovation agenda for Neuroscience, as evidenced by high value deals and significant portfolio impact; and may originate new strategic areas for Lilly. This role will be an active driver of the Neuroscience portfolio and the single point of accountability for Neuroscience search and evaluation, serving as the primary counterpart to Corporate Business Development (CBD), the Neuroscience Business Unit and Lilly Research Laboratories (LRL) leadership for external innovation in the therapeutic area. This role requires strong technical/scientific judgment, genuine business acumen, ability to lead people and portfolio, and the ability to set and influence strategy at the most senior levels of the company.

Key Responsibilities

This role's responsibilities center on three core areas — Search (identify partners and lead early assessment and triage of opportunities; serve as a key contact for partners), Evaluate (assess opportunities with rigorous scientific, technical and business judgment to identify key risks and inform decisions; lead pre-diligence and own scientific due diligence) and Advance (build organizational conviction and stakeholder alignment so that priority opportunities progress to deal completion and are set up to succeed after close) — together with leadership responsibility for the Neuroscience External Innovation team.

Strategy and portfolio

- Own and develop the external portfolio and innovation strategy for Neuroscience — defining where Lilly will focus externally (priority biology, modalities, platforms, diagnostics and biomarkers, and adjacencies), originating new areas, and translating internal portfolio priorities into actionable external search themes and landscapes; interact independently with senior management and a broad range of stakeholders (e.g., therapeutic area scientific leaders, New Product Planning/Commercial, Pricing, Reimbursement and Access, Finance, Corporate Business Development, Catalyze 360) to combine deep scientific knowledge with strategic insight.

- Own delivery of external innovation priorities and deals for Neuroscience across early- and late-phase opportunities. Stay at the forefront of external innovation practice and bring new approaches, tools and data sources (including AI-enabled landscape and scouting tools) into Lilly.

- Define and maintain disease-area landscapes; build investment theses, opportunity concept documents, competitive frames and explicit go/no-go criteria that make prioritization transparent and consistent.

Search

- Identify and search external innovation and/or collaboration opportunities — assets, portfolios, platforms and companies — through systematic landscape screens, scientific and partnering conferences, and a strong network across biotech, academia, venture capital and pharma; identify partners and lead early assessment of opportunities and triage against disease-area strategy.

Evaluate

- Lead and be responsible for initial technical evaluations, including leveraging therapeutic area-specific and cross-functional expertise where appropriate. Own Neuroscience's in-depth scientific due diligence, applying scientific, technical, and business judgment to identify the critical diligence questions, key opportunities and risks; resolve conflicts and align stakeholders. Consolidate assessment and feedback into clear, written, decision-ready recommendations (advance, hold or decline, with rationale), prepare management decks, and collaborate with Corporate Business Development and the Due Diligence team on evolution of deal structure and progression to close.

- Hold external and internal programs to the same evidentiary standard, and foster a culture of intellectual honesty in which an early, well-reasoned recommendation not to proceed is valued as highly as a completed deal.

Advance

- Apply strong business acumen across research and development, portfolio strategy, and commercialization to build organizational conviction behind priority opportunities, ensuring stakeholder alignment (therapeutic area, Business Unit, Corporate Business Development and Lilly Research Laboratories leadership) and conviction to support deal execution.

- Translate the scientific and strategic thesis into an initial deal construct — including structure, scope, and value rationale, with business terms aligned to key scientific and clinical inflection points — and lead early commercial conversations with partners to test and shape it before formalizing the deal team.

- Ensure a seamless transition of completed transactions to Alliance & Innovation Management and the receiving research or development teams, so that externally sourced programs are integrated and advanced without loss of momentum.

External representation

- Maintain deep scientific and competitive knowledge across internal portfolio projects, external opportunities, and emerging assets — spanning discovery through clinical development and platforms. Represent Lilly's strategic and external innovation priorities externally, including industry roundtables, invited presentations, and strong networks across biotech, venture, and pharma, and ensure Lilly is regarded as a partner of choice — responsive, transparent and constructive in its feedback to partners.

Governance and team leadership

- Represent external innovation for Neuroscience in relevant lead team meetings; chair the Neuroscience external innovation deal-flow review with therapeutic area and Corporate Business Development/External Innovation stakeholders; own selection of external innovation topics and presentations for senior management and governance forums.

- Lead, develop and, where needed, recruit the Neuroscience External Innovation team — setting evaluation standards and ways of working, supervising and coaching team members on scientific assessment, deal construction and governance communication, and supporting their professional and personal growth. Contribute actively to Lilly's cross-therapeutic-area Search & Evaluation community, sharing best practices and driving consistency.

Basic Requirements:

- Bachelor's and/or higher degree in a relevant area of science and/or healthcare.

- 10+ years of experience in the pharmaceutical industry, biotech, or ventures.

- 5+ years of experience in external innovation, search and evaluation, business development or venture roles involving systematic evaluation of external scientific opportunities, across multiple areas.
- 2+ years of supervisory (people management) experience.
- Strong scientific background in neuroscience or a related area, with a track record of accomplishments in drug discovery or development.

Additional Skills/Preferences:

- Ph.D. or equivalent in a relevant area of science is highly preferred

- MBA degree is a plus

- Deep understanding of neuroscience disease biology, unmet need, target landscape, emerging modalities and technologies (e.g., oligonucleotides, gene therapy and editing, protein degradation, blood–brain barrier delivery), fluid and imaging biomarkers, competition and portfolio trends across neurodegeneration, pain, psychiatry and sleep-wake disorders.

- Strong understanding of the strategic and financial considerations underlying deal priorities and partner considerations; working knowledge of a wide variety of deal structures, term-sheet economics and valuation approaches.

- Proven ability to define and develop new strategic areas, using scientific insight and the external environment as guidance.

- Proven track record of leading and driving high-value deals and the respective transaction teams across a range of deal structures and external partners, with evidence spanning several of the following: innovation acquisitions, multitarget platforms, co-development, newco/asset creation, and equity investments.

- Proven ability to drive deals in a matrix environment, partnering effectively with colleagues across science, business, finance, legal, and Corporate Business Development to ensure progression and closure of deals.

- Proven ability to set strategy and progress a portfolio of deals with minimal guidance.

- Proven track record of successfully leading a high-performing team with diverse people.

- Proven high ability in managing stakeholders across levels and functions and high influence on people and organization.

- Strong written and verbal communication skills; ability to articulate Lilly's strategy and priorities across a wide variety of settings, to produce concise, decision-ready written assessments, and to represent Lilly in a highly professional manner.

- You should have intellectual honesty and decision-making agility: comfortable with ambiguity, able to form and defend an independent view, and willing to change course quickly when the evidence warrants.

- Experience with AI-enabled landscape, competitive-intelligence and scouting tools.

- Experience in new company creation, venture capital interactions, healthcare consulting, or spinout management.

Additional Information:

- Travel: 30–40%, including international

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form ( https://careers.lilly.com/us/en/workplace-accommodation ) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.

Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.

Our employee resource groups (ERGs) offer strong support networks for their members and are open to all employees. Our current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women’s Initiative for Leading at Lilly (WILL).

Actual compensation will depend on a candidate’s education, experience, skills, and geographic location.  The anticipated wage for this position is
$247,500 - $363,000

###

Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.

#WeAreLilly